Skip to content
healthcare.dev

Alder Mix

NDC 49643-501, Alnus rhombifolia/Alnus rubra/Alnus rugosa, liquid, from Allermed Laboratories, Inc..

Product NDC
49643-501
Status
Listed
Labeler
Allermed Laboratories, Inc.
Dosage form
LIQUID
Route
PERCUTANEOUS, SUBCUTANEOUS
Product type
NON-STANDARDIZED ALLERGENIC
Marketing category
BLA
Application
BLA102211
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49643-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALNUS RHOMBIFOLIA POLLEN.0167 g/mL
  • ALNUS RUBRA POLLEN.0167 g/mL
  • ALNUS INCANA SUBSP. RUGOSA POLLEN.0167 g/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]

Package NDCNDC-11Package
49643-501-05496430501055 mL in 1 VIAL, MULTI-DOSE (49643-501-05)
49643-501-104964305011010 mL in 1 VIAL, MULTI-DOSE (49643-501-10)
49643-501-304964305013030 mL in 1 VIAL, MULTI-DOSE (49643-501-30)
49643-501-504964305015050 mL in 1 VIAL, MULTI-DOSE (49643-501-50)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 49643-501 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49643-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49643-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.